Handel Pluri Inc. - PLUR CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.0326 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.030779% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.013666% | ||||||||
Gebyr natten over, tid | 22:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | 1.1187 |
Åben* | 1.1187 |
1-Års Ændring* | -33.01% |
Dagens Spænd* | 1.0587 - 1.1287 |
52-Ugers Spænd | 0.65-2.21 |
Gennemsnitlig Volumen (10 dage) | 30.38K |
Gennemsnitlig Volumen (3 måneder) | 1.47M |
Market Cap | 34.94M |
P/E-forhold | -100.00K |
Udestående aktier | 32.66M |
Omsætning | 321.00K |
EPS | -1.12 |
Dividend (Udbytte %) | N/A |
Beta | 1.60 |
Næste indtjeningsopgørelse | N/A |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 1.0587 | -0.0600 | -5.36% | 1.1187 | 1.1287 | 1.0587 |
Feb 2, 2023 | 1.1187 | 0.0200 | 1.82% | 1.0987 | 1.1187 | 1.0787 |
Jan 27, 2023 | 1.1187 | -0.0299 | -2.60% | 1.1486 | 1.1586 | 1.1087 |
Jan 26, 2023 | 1.1287 | 0.0100 | 0.89% | 1.1187 | 1.1287 | 1.1187 |
Jan 25, 2023 | 1.0887 | 0.0000 | 0.00% | 1.0887 | 1.0887 | 1.0887 |
Jan 24, 2023 | 1.1586 | 0.0000 | 0.00% | 1.1586 | 1.1686 | 1.1586 |
Jan 20, 2023 | 1.1586 | -0.0400 | -3.34% | 1.1986 | 1.1986 | 1.1586 |
Jan 19, 2023 | 1.2286 | 0.0200 | 1.65% | 1.2086 | 1.2585 | 1.1686 |
Jan 18, 2023 | 1.2785 | 0.0599 | 4.92% | 1.2186 | 1.2785 | 1.2186 |
Jan 17, 2023 | 1.2585 | 0.0799 | 6.78% | 1.1786 | 1.3285 | 1.1786 |
Jan 13, 2023 | 1.2086 | 0.1399 | 13.09% | 1.0687 | 1.3984 | 1.0687 |
Jan 12, 2023 | 1.0288 | 0.0000 | 0.00% | 1.0288 | 1.0687 | 1.0288 |
Jan 11, 2023 | 1.0088 | -0.0200 | -1.94% | 1.0288 | 1.0288 | 1.0088 |
Jan 9, 2023 | 1.0288 | 0.0300 | 3.00% | 0.9988 | 1.0588 | 0.9988 |
Jan 6, 2023 | 0.9986 | 0.0435 | 4.55% | 0.9551 | 1.0288 | 0.9551 |
Jan 5, 2023 | 0.9550 | -0.0299 | -3.04% | 0.9849 | 0.9850 | 0.9489 |
Jan 4, 2023 | 0.9987 | 0.0039 | 0.39% | 0.9948 | 0.9988 | 0.9948 |
Jan 3, 2023 | 0.9916 | 0.0067 | 0.68% | 0.9849 | 0.9985 | 0.9788 |
Dec 30, 2022 | 0.9352 | -0.0065 | -0.69% | 0.9417 | 0.9489 | 0.9352 |
Dec 29, 2022 | 0.9277 | -0.0175 | -1.85% | 0.9452 | 0.9551 | 0.9203 |
Pluri Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total omsætning | 2.847 | 0 | 0.05 | 0.054 | 0.023 | 0 |
Omsætning | 2.847 | 0 | 0.05 | 0.054 | 0.023 | 0 |
Kost af omsætning, Total | 0.1 | 0 | 0.002 | 0.002 | 0 | 0 |
Bruttofortjeneste | 2.747 | 0 | 0.048 | 0.052 | 0.023 | 0 |
Totale Driftsudgifter | 26.166 | 28.019 | 33.781 | 35.586 | 29.499 | 50.623 |
Salgs/Generelle/Admin. Udgifter, Total | 6.486 | 6.927 | 11.193 | 9.157 | 7.922 | 20.557 |
Forskning & Udvikling | 20.85 | 21.972 | 24.478 | 12.841 | 21.643 | 13.47 |
Depreciation / Amortization | 2.006 | 2.029 | 1.893 | 1.841 | 1.453 | 1.252 |
Other Operating Expenses, Total | -3.276 | -2.909 | -3.785 | 11.745 | -1.519 | 15.344 |
Driftsindtægter | -23.319 | -28.019 | -33.731 | -35.532 | -29.476 | -50.623 |
Renteindkomst (Udgift), Netto Ikke-Drift | 0.109 | 0.272 | 8.542 | 0.105 | 0.356 | 0.781 |
Andre, Netto | -0.036 | -0.067 | -0.937 | 0.12 | -0.032 | -0.023 |
Netto Indkomst Før Skat | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Netto Indkomst Efter Skat | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Netto Indkomst Før Ekstra Ting | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Netto Indkomst | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Fortyndet Netto Indkomst | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Fortyndet Vægtet Gennemsnit Aktier | 7.9548 | 8.74262 | 10.5877 | 1.23329 | 18.1973 | 28.1136 |
Fortyndet EPS Uden Ekstraordinære Ting | -2.92226 | -3.18143 | -2.46759 | -28.6283 | -1.602 | -1.77369 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
Fortyndet Normaliseret EPS | -2.85237 | -3.12149 | -2.38995 | -28.1158 | -1.5688 | -1.74709 |
Q3 2021 | Q4 2021 | Q1 2021 | Q2 2021 | Q3 2022 | |
---|---|---|---|---|---|
Total omsætning | 0 | 0 | 0 | 0 | 0.234 |
Omsætning | 0 | 0 | 0.234 | ||
Kost af omsætning, Total | 0 | 0 | |||
Bruttofortjeneste | 0 | 0 | |||
Totale Driftsudgifter | 14.225 | 14.587 | 11.441 | 10.795 | 10.709 |
Salgs/Generelle/Admin. Udgifter, Total | 6.559 | 6.102 | 5.088 | 4.288 | 4.553 |
Forskning & Udvikling | 7.824 | 8.507 | 6.391 | 6.541 | 6.273 |
Other Operating Expenses, Total | -0.158 | -0.022 | -0.038 | -0.034 | -0.117 |
Driftsindtægter | -14.225 | -14.587 | -11.441 | -10.795 | -10.475 |
Renteindkomst (Udgift), Netto Ikke-Drift | -0.029 | 0.019 | 0.009 | -0.145 | 0.557 |
Netto Indkomst Før Skat | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Netto Indkomst Efter Skat | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Netto Indkomst Før Ekstra Ting | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Netto Indkomst | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Fortyndet Netto Indkomst | -14.254 | -14.568 | -11.432 | -10.94 | -9.918 |
Fortyndet Vægtet Gennemsnit Aktier | 29.6172 | 31.6441 | 32.0008 | 32.1363 | 32.2616 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.48127 | -0.46037 | -0.35724 | -0.34042 | -0.30742 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Fortyndet Normaliseret EPS | -0.48127 | -0.46037 | -0.35724 | -0.34042 | -0.30742 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Nuværende Aktiver | 35.596 | 29.016 | 32.036 | 26.371 | 48.461 | 67.371 |
Likvider og Kortsigtede Investeringer | 32.208 | 26.106 | 29.9 | 23.705 | 45.784 | 64.95 |
Likvider & Lignende | 6.223 | 4.707 | 8.821 | 4.106 | 8.27 | 31.241 |
Kortsigtede Investeringer | 25.985 | 21.399 | 21.079 | 19.599 | 37.514 | 33.709 |
Totale Tilgodehavender, Netto | 2.481 | 1.174 | 0.847 | 1.421 | 1.61 | 1.49 |
Accounts Receivable - Trade, Net | 2.251 | 1.036 | 0.69 | 1.243 | 1.248 | 1.108 |
Prepaid Expenses | 0.3 | 0.882 | 0.602 | 0.532 | 0.445 | 0.333 |
Other Current Assets, Total | 0.607 | 0.854 | 0.687 | 0.713 | 0.622 | 0.598 |
Total Assets | 45.941 | 37.534 | 38.96 | 31.31 | 65.532 | 93.538 |
Property/Plant/Equipment, Total - Net | 9.216 | 7.277 | 5.678 | 3.838 | 3.775 | 2.227 |
Property/Plant/Equipment, Total - Gross | 17.183 | 16.507 | 16.893 | 17.004 | 18.437 | 18.259 |
Accumulated Depreciation, Total | -7.967 | -9.23 | -11.215 | -13.166 | -14.662 | -16.032 |
Long Term Investments | 0.363 | 0.403 | 0.383 | 0.398 | 12.653 | 23.269 |
Other Long Term Assets, Total | 0.766 | 0.838 | 0.863 | 0.703 | 0.643 | 0.671 |
Total Current Liabilities | 5.775 | 5.414 | 8.548 | 8.158 | 7.987 | 11.517 |
Accounts Payable | 2.705 | 1.966 | 3.261 | 2.281 | 1.968 | 2.526 |
Accrued Expenses | 2.819 | 3.106 | 4.164 | 5.637 | 5.893 | 8.951 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.251 | 0.342 | 1.123 | 0.24 | 0.126 | 0.04 |
Total Liabilities | 7.785 | 7.283 | 10.453 | 9.489 | 9.431 | 36.387 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 | 23.85 |
Other Liabilities, Total | 2.01 | 1.869 | 1.905 | 1.331 | 1.444 | 1.02 |
Total Equity | 38.156 | 30.251 | 28.507 | 21.821 | 56.101 | 57.151 |
Common Stock | 0.001 | 0.001 | 0.001 | 0.001 | ||
Additional Paid-In Capital | 198.432 | 217.822 | 244.203 | 272.824 | 336.257 | 387.172 |
Retained Earnings (Accumulated Deficit) | -161.757 | -189.571 | -215.697 | -251.004 | -280.156 | -330.021 |
Unrealized Gain (Loss) | 1.48 | 1.48 | 8.44 | |||
Other Equity, Total | 0 | 0.519 | -8.44 | |||
Total Liabilities & Shareholders’ Equity | 45.941 | 37.534 | 38.96 | 31.31 | 65.532 | 93.538 |
Total Common Shares Outstanding | 8.0269 | 9.69388 | 11.3566 | 15.0829 | 25.4927 | 31.9578 |
Long Term Debt | 23.85 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 49.82 | 67.371 | 62.826 | 60.153 | 64.313 |
Likvider og Kortsigtede Investeringer | 47.37 | 64.95 | 60.671 | 58.183 | 61.98 |
Likvider & Lignende | 12.265 | 31.241 | 14.611 | 18.715 | 23.791 |
Kortsigtede Investeringer | 35.105 | 33.709 | 46.06 | 39.468 | 38.189 |
Other Current Assets, Total | 2.45 | 2.421 | 2.155 | 1.97 | 2.333 |
Total Assets | 79.174 | 93.538 | 83.747 | 81.184 | 79.127 |
Property/Plant/Equipment, Total - Net | 2.713 | 2.227 | 1.749 | 9.331 | 9.14 |
Long Term Investments | 25.937 | 23.269 | 18.483 | 10.965 | 4.235 |
Other Long Term Assets, Total | 0.704 | 0.671 | 0.689 | 0.735 | 1.439 |
Total Current Liabilities | 9.916 | 11.517 | 10.365 | 9.595 | 7.822 |
Accounts Payable | 2.11 | 2.526 | 3.723 | 4.058 | 3.942 |
Accrued Expenses | 5.613 | 6.575 | 6.642 | 5.537 | 3.88 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.193 | 2.416 | |||
Total Liabilities | 11.038 | 36.387 | 34.84 | 41.344 | 41.034 |
Total Long Term Debt | 0 | 23.85 | 23.444 | 23.158 | 22.924 |
Other Liabilities, Total | 1.122 | 1.02 | 1.031 | 8.591 | 8.238 |
Total Equity | 68.136 | 57.151 | 48.907 | 39.84 | 38.0933 |
Additional Paid-In Capital | 383.589 | 387.172 | 390.36 | 392.233 | 400.351 |
Retained Earnings (Accumulated Deficit) | -315.453 | -330.021 | -341.453 | -352.393 | -362.258 |
Total Liabilities & Shareholders’ Equity | 79.174 | 93.538 | 83.747 | 81.184 | 79.1273 |
Total Common Shares Outstanding | 31.7402 | 31.9578 | 32.0969 | 32.2251 | 32.3424 |
Totale Tilgodehavender, Netto | 0 | ||||
Accounts Receivable - Trade, Net | 0 | ||||
Current Port. of LT Debt/Capital Leases | 0 | ||||
Long Term Debt | 23.85 | 23.444 | 23.158 | 22.924 | |
Common Stock | 0.00032 | 0.00032 | |||
Other Equity, Total | -0.00032 | ||||
Minority Interest | 2.05 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto indkomst/Startlinje | -23.246 | -27.814 | -26.126 | -35.307 | -29.152 | -49.865 |
Likvider Fra Driftsaktiviteter | -18.522 | -21.611 | -21.38 | -29.453 | -26.369 | -30.91 |
Likvider Fra Driftsaktiviteter | 2.15 | 2.177 | 2.018 | 1.962 | 1.57 | 1.37 |
Ikke-Likvide Ting | 3.498 | 4.174 | -1.025 | 5.146 | 2.562 | 13.968 |
Cash Taxes Paid | 0.066 | 0.028 | 0.027 | 0.01 | 0.01 | |
Ændringer i Driftskapital | -0.924 | -0.148 | 3.753 | -1.254 | -1.349 | 3.617 |
Likvider fra Investeringsaktiviteter | 1.312 | 4.355 | 5.681 | 1.17 | -30.458 | -7.265 |
Kapitaludgifter | -1.75 | -0.378 | -0.342 | -0.239 | -0.27 | -0.373 |
Andre Investerings-Cash-Flow-Ting, Total | 3.062 | 4.733 | 6.023 | 1.409 | -30.188 | -6.892 |
Likvider fra Financieringsaktiviteter | 0.807 | 15.797 | 19.921 | 23.582 | 60.87 | 61.402 |
Udstedelse (Pensionering) af Aktier, Netto | 0.807 | 15.728 | 19.833 | 23.475 | 60.87 | 36.953 |
Netto Ændring i Likviditet | -16.403 | -1.459 | 4.222 | -4.701 | 4.043 | 22.609 |
Financiering af Cash-Flow-Ting | 0.069 | 0.088 | 0.107 | 0 | ||
Udstedelse (Pensionering) af Gæld, Netto | 24.449 | |||||
Udenlandsk Børs Effekter | -0.618 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -35.297 | -49.865 | -11.432 | -22.372 | -32.29 |
Cash From Operating Activities | -21.313 | -30.91 | -8.789 | -18.652 | -28.074 |
Cash From Operating Activities | 1.034 | 1.37 | 0.337 | 0.664 | 0.915 |
Non-Cash Items | 10.382 | 13.968 | 3.188 | 6.1 | 7.782 |
Cash Taxes Paid | 0.008 | ||||
Changes in Working Capital | 2.568 | 3.617 | -0.882 | -3.044 | -4.481 |
Cash From Investing Activities | -12.057 | -7.265 | -7.24 | 7.075 | 14.738 |
Capital Expenditures | -0.331 | -0.373 | -0.015 | -0.044 | -0.081 |
Other Investing Cash Flow Items, Total | -11.726 | -6.892 | -7.225 | 7.119 | 14.819 |
Cash From Financing Activities | 36.992 | 61.402 | 0 | 0 | 7.5 |
Issuance (Retirement) of Stock, Net | 36.992 | 36.953 | 0 | 0 | 0 |
Net Change in Cash | 3.622 | 22.609 | -16.62 | -12.616 | -6.908 |
Issuance (Retirement) of Debt, Net | 24.449 | ||||
Foreign Exchange Effects | -0.618 | -0.591 | -1.039 | -1.072 | |
Financing Cash Flow Items | 7.5 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Yanay (Yaky) | Individual Investor | 3.2937 | 1075620 | 396790 | 2022-12-22 | LOW |
Regals Capital Management, L.P. | Investment Advisor | 3.2824 | 1071938 | 1071938 | 2022-01-24 | |
Aberman (Zalman) | Individual Investor | 2.5434 | 830604 | -2000 | 2022-12-20 | LOW |
Slager (David M) | Individual Investor | 1.8774 | 613100 | 613100 | 2022-01-24 | HIGH |
Meitav Dash Investments Ltd. | Investment Advisor | 0.5132 | 167593 | 0 | 2022-09-30 | LOW |
Nia Impact Capital | Investment Advisor | 0.4071 | 132947 | -318394 | 2022-09-30 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.3235 | 105657 | -174105 | 2022-09-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.3197 | 104400 | -2900 | 2022-09-30 | HIGH |
Bridgeway Capital Management, LLC | Investment Advisor | 0.3142 | 102600 | -10000 | 2022-09-30 | LOW |
Nikko Asset Management Americas, Inc. | Investment Advisor/Hedge Fund | 0.2574 | 84056 | -20865 | 2021-12-31 | LOW |
Franco-Yehuda (Chen) | Individual Investor | 0.225 | 73466 | 6875 | 2022-12-21 | LOW |
Green Alpha Advisors, LLC | Investment Advisor | 0.1794 | 58603 | 2377 | 2022-12-31 | HIGH |
Values First Advisors, Inc. | Investment Advisor | 0.1398 | 45653 | -2677 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.1211 | 39544 | 0 | 2022-12-31 | LOW |
Jane Street Capital, L.L.C. | Research Firm | 0.1102 | 35986 | -46524 | 2022-09-30 | HIGH |
Group One Trading, L.P. | Research Firm | 0.0877 | 28638 | -5900 | 2022-09-30 | HIGH |
Zürcher Kantonalbank (Asset Management) | Bank and Trust | 0.0842 | 27497 | -137 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.0771 | 25169 | 0 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 0.0625 | 20412 | -120303 | 2022-09-30 | HIGH |
Archford Capital Strategies, LLC | Investment Advisor | 0.0401 | 13091 | 0 | 2022-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com GroupHandlende
Månedlkige, aktive klienter
Månedlig investeringsvolumen
Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Pluri Inc. Company profile
Om Pluristem Therapeutics Inc.
Pluristem Therapeutics Inc. er en udvikler af placentabaserede celleterapi produktkandidater til behandling af flere ischæmiske, inflammatoriske og hæmatologiske tilstande. Selskabets hovedindikationer er kritisk lemiskæmi (CLI), genopretning efter operation for lårhalsbrud og akut strålingssyndrom. Virksomhedens aktiviteter er fokuseret på forskning, udvikling, kliniske forsøg og fremstilling af celleterapeutika og relaterede teknologier. Virksomhedens produkter omfatter PLX-PAD og PLX R18. Selskabets PLX-celler er adhærente stromaceller (ASC'er), der ekspanderes ved hjælp af en tredimensionel (3D) proces. Systemet anvender et syntetisk stillads til at skabe et kunstigt 3D-miljø, hvor placentaafledte stromale celler kan vokse. Virksomhedens PLX-produkter administreres ved hjælp af en standardnål og -sprøjte. Selskabets PLX-produkter er i den kliniske udviklingsfase for flere forskellige indikationer, f.eks. kardiovaskulære, ortopædiske, lungesygdomme og kvindesygdomme.
Industry: | Biotechnology & Medical Research (NEC) |
MATAM Advanced Technology Park
Building #5
3508409
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com